Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Berkeley Heights, New Jersey
- Most recent report
- 10-Q, filed Nov 9, 2026
- Incorporated
- Nevada
- Filings on record
- 1,002+ filings
- On EDGAR
- CIK 1430306
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 41
News 8 of 522
Prospectuses and Registrations 8 of 87
- S-8 Registration statement for an employee plan Jul 1, 2026
- 424B5 Prospectus supplement for an offering Dec 29, 2025
- 424B5 Prospectus supplement for an offering Nov 21, 2025
- S-3/A Shelf registration statement, amended Sep 4, 2025
- S-3 Shelf registration statement Jun 12, 2025
- 424B5 Prospectus supplement for an offering Jun 11, 2025
- 424B5 Prospectus supplement for an offering Jun 11, 2025
- S-8 Registration statement for an employee plan May 30, 2025
Proxies 8 of 35
- DEF 14A Proxy statement for a shareholder vote Mar 30, 2026
- PRE 14A Preliminary proxy statement Mar 20, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 31, 2025
- PRE 14A Preliminary proxy statement Mar 21, 2025
- DEF 14A Proxy statement for a shareholder vote Sep 23, 2024
- PRE 14A Preliminary proxy statement Sep 13, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 15, 2024
- PRE 14A Preliminary proxy statement Apr 5, 2024
Ownership 8 of 255
- 3 Insider reported their initial holding Sep 8, 2026
- 4 Insider reported a trade Aug 31, 2026
- 4 Insider reported a trade Aug 24, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 13, 2026
- 4 Insider reported a trade Jul 9, 2026
- SCHEDULE 13G Large holder reported a passive stake Jun 15, 2026
- 4 Insider reported a trade Jun 15, 2026
Other 8 of 62
- ARS Annual report sent to shareholders Mar 13, 2026
- EFFECT Notice that a registration became effective Sep 4, 2025
- CORRESP Reply to SEC staff Sep 3, 2025
- CORRESP Reply to SEC staff Sep 3, 2025
- CORRESP Reply to SEC staff Aug 29, 2025
- UPLOAD Comment letter from SEC staff Jun 16, 2025
- ARS Annual report sent to shareholders Mar 18, 2025
- EFFECT Notice that a registration became effective Sep 30, 2024
Everything here comes from Tonix Pharmaceuticals Holding Corp.'s own filings on SEC EDGAR. The filing list is rechecked every hour.